Avita Medical | Brutto Fortjeneste På Salg



Gross Profit On Sales Endring Dato
Adcock Ingram Holdings ZAR 1.61B 802K 2024-06
Celltrion KRW 463.41B 95.59B 2024-09
Clinuvel Pharmaceuticals AUD 57.82M 18.86M 2024-06
Cochlear AUD 867.2M 38.9M 2024-06
CSL USD 3.34B 991M 2024-06
Cspc Pharmaceutical CNY 4.33B 828.42M 2024-09
Ecofibre AUD 2.08M 4.33M 2024-06
Kangmei Pharma CNY 176.17M 370.88K 2024-09
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 110.32M 24.65M 2024-06
Malin Corporation EUR 3.8M 2.6M 2020-12
Mayne Pharma AUD 115.99M 63.1M 2024-06
Medical Developments International AUD 13.36M 2.36M 2024-06
Nanosonics AUD 34.5M 28.94M 2024-06
Opthea USD 212.56K 300.45K 2024-06
Organigram Holdings CAD 1.05M 67.34M 2024-12
Pacific Edge 283K 0 2024-03
Paradigm Biopharmaceuticals AUD 5.24M 3.96M 2024-06
Pharma Mar EUR 47.05M 3.4M 2024-12
Polynovo AUD 23.26M 22.74M 2024-06
PYC Therapeutics AUD 6.58M 2.13M 2024-06
Qiagen NV USD 349.8M 19.17M 2024-12
Ramsay Health Care AUD 6.32B 20.5M 2024-12
ResMed USD 751.28M 34.06M 2024-12
Sartorius EUR 345.1M 43.2M 2024-09
Sino Biopharmaceutical CNY 6.51B 2.67B 2024-06
Telix Pharmaceuticals AUD 225.7M 52.36M 2024-06
Tilray USD 61.22M 1.51M 2024-11
Zz Pientze Pharmaceu 1.29B 268M 2024-09



Avita Medical Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.